Cellular response to small molecules that selectively stall protein synthesis by the ribosome.
Identifying small molecules that inhibit protein synthesis by selectively stalling the ribosome constitutes a new strategy for therapeutic development. Compounds that inhibit the translation of PCSK9, a major regulator of low-density lipoprotein cholesterol, have been identified that reduce LDL chol...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-03-01
|
| Series: | PLoS Genetics |
| Online Access: | http://europepmc.org/articles/PMC6436758?pdf=render |